Researchers based at the University of Ulsan College of Medicine in the Republic...
- PET/CT imaging agent could improve acute venous thromboembolism diagnosis
- FDA clears Tandem Diabetes’ t:Slim X2 insulin pump
- Medtronic partners with US university to boost patient care
- Nuvaira secures funds to develop lung denervation system
- Medtronic gets expanded indication for Pipeline Flex in US
PET/CT imaging agent could improve acute venous thromboembolism diagnosis
Researchers based at the University of Ulsan College of Medicine in the Republic of Korea have found that the positron emission tomography/computed tomography (PET/CT) tracer 18F-GP1 results in high image quality and a high detection rate for acute venous thromboembolism (VTE).
Researchers develop electrode for less invasive neural stimulation
A research team at the University of Pittsburgh in the US has developed a new electrode to facilitate less invasive neural stimulation for the treatment of neurological conditions such as Parkinson’s disease.
FDA clears Tandem Diabetes’ t:Slim X2 insulin pump
The US Food and Drug Administration (FDA) has granted marketing clearance for the Tandem Diabetes Care’s t:Slim X2 insulin pump, which can deliver insulin under the skin in children and adults with diabetes.
Medtronic partners with US university to boost patient care
Irish medical device giant Medtronic has partnered with Medical University of South Carolina (MUSC) in the US to transform and enhance patient care in the region.
Nuvaira secures funds to develop lung denervation system
US-based medical device company Nuvaira has raised fresh funds in an equity financing round led by US Venture Partners to further develop its lung denervation system for treating chronic obstructive pulmonary disease (COPD) and asthma.
Medtronic gets expanded indication for Pipeline Flex in US
The US Food and Drug Administration (FDA) has granted approval for an expanded indication of Medtronic’s Pipeline Flex embolisation device for brain aneurysms.
Cognoa devices for autism obtain FDA breakthrough status
Cognoa, a digital devices maker, has obtained the US Food and Drug Administration (FDA) breakthrough device designation for its diagnostic and therapeutic devices intended for autism spectrum disorder (ASD).
AtriCure treats first Afib patient with cryoICE Ablation System
Medical technologies developer AtriCure has started enrolment and treatment in the prospective ICE-AFIB clinical trial of its cryoICE Ablation System in atrial fibrillation (Afib) patients.
Honda to trial Walking Assist Device in Parkinson’s patients
Honda R&D Americas has received a grant from the Michael J. Fox Foundation (MJFF) to study the safety and impact of its Walking Assist Device in Parkinson's disease (PD) patients.
Balloon-guided catheters provide better post-stroke blood flow, study finds
A multi-centre team of US researchers has found that balloon-guided catheter surgery can result in better outcomes for patients who have had a stroke due to brain artery blockages than conventional guided catheter procedures.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.